Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT)

BACKGROUND: Artemether-lumefantrine (ALu) replaced sulphadoxine-pymimethamine (SP) as the official first-line anti-malarial in Tanzania in November 2006. So far, artemisinin combination therapy (ACT) is contra-indicated during pregnancy by the national malaria treatment guidelines, and pregnant wome...

Descripción completa

Detalles Bibliográficos
Autores principales: Ringsted, Frank M, Massawe, Isolide S, Lemnge, Martha M, Bygbjerg, Ib C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167767/
https://www.ncbi.nlm.nih.gov/pubmed/21843328
http://dx.doi.org/10.1186/1475-2875-10-238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167767/
https://www.ncbi.nlm.nih.gov/pubmed/21843328
http://dx.doi.org/10.1186/1475-2875-10-238

Ejemplares similares